Mitsuyuki Suzuki
Niigata, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Evaluation of hepatitis B virus reactivation prevention measures in immunosuppressed patients: current status and effectiveness.
Journal: Translational gastroenterology and hepatology
Published: August 08, 2024
Serum zinc concentration as a potential predictor of presarcopenia in patients with chronic liver disease: a preliminary study.
Journal: Translational gastroenterology and hepatology
Published: September 19, 2023
Optimal Skeletal Muscle Mass Index Cut-Off Values for Presarcopenia Evaluated by Computed Tomography against Dual-Energy X-ray Absorptiometry in Patients with Chronic Liver Disease.
Journal: Journal of clinical medicine
Published: February 22, 2021
Effect of levocarnitine administration in patients with chronic liver disease.
Journal: Experimental and therapeutic medicine
Published: March 05, 2020
Advanced Age is not a Risk Factor for Mortality in Patients with Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Organisms: a Multicenter Cohort Study.
Journal: Japanese journal of infectious diseases
Published: March 03, 2020
Efficacy of Physical Activity in Prevention of Muscle Weakness in Patients With Chronic Liver Disease.
Journal: Journal of clinical medicine research
Published: September 02, 2019
Relationship between pre-sarcopenia and quality of life in patients with chronic liver disease: a cross-sectional study.
Journal: European journal of gastroenterology & hepatology
Published: April 10, 2019
Relationship Between Sarcopenia and Both Physical Activity and Lifestyle in Patients With Chronic Liver Disease.
Journal: Journal of clinical medicine research
Published: September 28, 2018
Health-related quality of life on the clinical course of patients with chronic hepatitis C receiving daclatasvir/asunaprevir therapy: A prospective observational study comparing younger (<70) and elderly (≥70) patients.
Journal: Experimental and therapeutic medicine
Published: June 04, 2017
Evaluation of the health-related quality of life using the 36-item short form health survey in patients with chronic hepatitis C receiving pegylated interferon/ribavirin/telaprevir triple treatment.
Journal: Experimental and therapeutic medicine
Published: October 06, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026